The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT

Nuclear Medicine Communications

Volumn 30, Issue 5, 2009, Pages 333-337

  Lee, Joseph C ^a,b   Hartnett, Gemma F ^a   Hughes, Brett G M ^a   Ravi Kumar, Aravind S ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Medication Services Queensland   (Australia)

Author keywords

Colonic adenoma; Colonic neoplasm; Colorectal carcinoma; Fluorodeoxyglucose; PET computed tomography; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; COLON ADENOMA; COLON TUMOR; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DESCENDING COLON; DRUG UPTAKE; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; RECTUM;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 67649574531     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832999fa     Document Type: Article

References (15)

1. Scott AM. Current status of positron emission tomography in oncology. Intern Med J 2001; 31:27-36.
2. Even-Sapir E, Lerman H, Gutman M, Lievshitz G, Zuriel L, Polliack A, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 2006; 33:541-552.
3. Agress H Jr, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 2004; 230:417-422.
4. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005; 46:752-757.
5. Arslan N, Dehdashti F, Siegel BA. FDG uptake in colonic villous adenomas. Ann Nucl Med 2005; 19:331-334.
6. Van Kouwen MCA, Nagengast FM, Jansen JBMJ, Oyen WJG, Drenth JPH. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005; 23:3713-3717.
7. Yasuda S, Fujii H, Nakahara T, Nishiumi N, TakhashiW, Ide M, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med 2001; 42:989-992.
8. Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005; 46:758-762.
9. Kamel EM, Thumshirn M, Truninger K, Schiesser M, Fried M, Padberg B, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 2004; 45:1804-1810.
10. Gutman F, Alberini J-L, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 2005; 185:495-500.
11. Pandit-Taskar N, Schoder H, Gonen M, Larson SM, Yeung HWD. Clinical Significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR Am J Roentgenol 2004; 183:1143-1147.
12. Rex DK. Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol 2006; 101:2866-2877.
13. Drenth JPH, Magengast FM, Oyen WJG. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med 2001; 28:1766-1769.
14. Nicholson FB, Korman MG, Stern AI, Hansky J. Distribution of colorectal adenomas: implications for bowel cancer screening. Med J Aust 2000; 172:428-430.
15. Davis NC, Evans EB, Cohen JR, Thiele DE, Job DM. Colorectal cancer: a large unselected Australian series. Aust N Z J Surg 1987; 57:153-159.